SCHEMBL2783773

SCHEMBL2783773

Nc1ccc2cc3c(N)ccc(C(O)(C(F)(F)F)C(F)(F)F)c3cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ GLA P06280 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ LMNA P02545 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ CYP3A4 P08684 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2783673 1.00 ALDH1A1 (0.46) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2783264 0.86 SMN1; SMN2 (0.50) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2784631 0.86 SMN1; SMN2 (0.50) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2785174 0.85 SMN1; SMN2 (0.49) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2782955 0.85 SMN1; SMN2 (0.49) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2784727 0.85 SMN1; SMN2 (0.55) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2786584 0.83 ALDH1A1 (0.56) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2783353 0.83 ALDH1A1 (0.56) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2784017 0.82 SMN1; SMN2 (0.49) ALDH1A1HSD17B10KDM4EMEN1MAPT
SCHEMBL2784057 0.82 SMN1; SMN2 (0.49) ALDH1A1HSD17B10KDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130085237-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2013-04-04 — — US disclosed
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2010-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom AFF2, AFF1, AFF4 ALDH1A1 931/4885HSD17B10 3598/4885KDM4E 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback